Label Image (Lbl530023713)
Rizatriptan Benzoate
Product Images NDC 53002-3713
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 53002-3713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Rizatriptan-fig-1 (Rizatriptan Fig 1)
This is a graph showing the probability of response to Rizatriptan Benzoate at 5mg and 10mg doses and a Placebo. The X-axis represents the Hours Post-Dose and the Y-axis represents the Probability of Response. The graph indicates that Rizatriptan Benzoate at 5mg and 10mg doses has a higher probability of response than the Placebo. The text is readable.*
Rizatriptan-fig-2 (Rizatriptan Fig 2)
This appears to be a graph displaying estimated probabilities of remedication or rescue after taking different doses of rizatriptan benzoate, a medication used to treat migraines. The graph shows that the probability of remedication or rescue is 100% for both 5 mg and 10 mg doses, represented by the larger bars on the graph. The smaller bars represent a placebo. The x-axis shows the number of hours post-dose and the y-axis represents percentage probability.*
Rizatriptan-fig-5 (Rizatriptan Fig 5)
Rizatriptan-structure (Rizatriptan Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
